Marius Pharmaceuticals, a pharmaceutical company focused on developing innovative therapies for testosterone deficiency, has released compelling new insights from a recent Androgen Deficiency in Aging ...
Leerink Partners analyst Joseph Schwartz has reiterated their bullish stance on MREO stock, giving a Buy rating on November 12. Joseph ...